ID   NCF3
AC   CVCL_IN83
DR   Wikidata; Q54907700
RX   PubMed=2470608;
RX   PubMed=15463957;
CC   Doubling time: ~48 hours (PubMed=2470608).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=2470608).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; Note=From a nasal polyp; UBERON=UBERON_0005384.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=2470608; DOI=10.1016/0014-4827(89)90259-0;
RA   Scholte B.J., Kansen M., Hoogeveen A.T., Willemse R., Rhim J.S.,
RA   van der Kamp A.W.M., Bijman J.;
RT   "Immortalization of nasal polyp epithelial cells from cystic fibrosis
RT   patients.";
RL   Exp. Cell Res. 182:559-571(1989).
//
RX   PubMed=15463957; DOI=10.1016/j.jcf.2004.05.040;
RA   Gruenert D.C., Willems M., Cassiman J.-J., Frizzell R.A.;
RT   "Established cell lines used in cystic fibrosis research.";
RL   J. Cyst. Fibros. 3:191-196(2004).
//